147 related articles for article (PubMed ID: 15492751)
1. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
Bataille F; Rogler G; Modes K; Poser I; Schuierer M; Dietmaier W; Ruemmele P; Mühlbauer M; Wallner S; Hellerbrand C; Bosserhoff AK
Lab Invest; 2005 Jan; 85(1):124-36. PubMed ID: 15492751
[TBL] [Abstract][Full Text] [Related]
2. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
3. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
[TBL] [Abstract][Full Text] [Related]
4. [Expression of methylthioadenosine phosphorylase (MTAP) gene and demethylation of its promoter in human colorectal cancer].
Dou JX; Zhang WD; Li WT; Li HL; Cai XS; Liu J
Ai Zheng; 2009 Apr; 28(4):390-4. PubMed ID: 19622299
[TBL] [Abstract][Full Text] [Related]
5. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
6. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).
Kirovski G; Stevens AP; Czech B; Dettmer K; Weiss TS; Wild P; Hartmann A; Bosserhoff AK; Oefner PJ; Hellerbrand C
Am J Pathol; 2011 Mar; 178(3):1145-52. PubMed ID: 21356366
[TBL] [Abstract][Full Text] [Related]
8. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
9. Methylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinoma.
Conde L; Vilaseca I; Alós L; Bernal-Sprekelsen M; Cardesa A; Nadal A
Histopathology; 2012 Dec; 61(6):1082-8. PubMed ID: 23020581
[TBL] [Abstract][Full Text] [Related]
10. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
Chen ZH; Olopade OI; Savarese TM
Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
[TBL] [Abstract][Full Text] [Related]
11. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
12. Methylthioadenosine phosphorylase expression in cutaneous squamous cell carcinoma.
Alhebshi HM; Pant I; Kaur G; Hashim H; Mabruk MJ
Asian Pac J Cancer Prev; 2008; 9(2):291-4. PubMed ID: 18712977
[TBL] [Abstract][Full Text] [Related]
13. Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
de Oliveira SF; Ganzinelli M; Chilà R; Serino L; Maciel ME; Urban Cde A; de Lima RS; Cavalli IJ; Generali D; Broggini M; Damia G; Ribeiro EM
PLoS One; 2016; 11(1):e0145647. PubMed ID: 26751376
[TBL] [Abstract][Full Text] [Related]
14. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
15. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Subhi AL; Tang B; Balsara BR; Altomare DA; Testa JR; Cooper HS; Hoffman JP; Meropol NJ; Kruger WD
Clin Cancer Res; 2004 Nov; 10(21):7290-6. PubMed ID: 15534104
[TBL] [Abstract][Full Text] [Related]
16. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.
Zhang H; Chen ZH; Savarese TM
Cancer Genet Cytogenet; 1996 Jan; 86(1):22-8. PubMed ID: 8616780
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of methylthioadenosine phosphorylase gene in patients with non-small cell lung cancer].
Dai WM; Li BY; Yu CH; Chu XY; Zhang KT
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):907-9. PubMed ID: 15329275
[TBL] [Abstract][Full Text] [Related]
18. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
[TBL] [Abstract][Full Text] [Related]
19. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase-deficient mutant clones of murine lymphoma cell line R1.1.
Kadariya Y; Nishioka J; Nakamura A; Kato-Nakazawa K; Nobori T
Cancer Sci; 2003 Jun; 94(6):519-22. PubMed ID: 12824877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
